DRTS · Nasdaq, Nasdaq · CIK 0001871321
Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd.’s most recent SEC filing in our snapshot is a Form 6-K filed on Oct 22, 2026. Its EDGAR record lists 9 Form 4 insider filings from the 12 months before our last refresh.
SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.
Company overview
- Legal name (as filed)
- Alpha Tau Medical Ltd.
- Tickers
- DRTS, DRTSW
- SEC Central Index Key (CIK)
- 0001871321
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus (code 3841)
- Business address
- JERUSALEM, Israel
- State or country of incorporation
- Israel
- Fiscal year ends
- December 31
- SEC filer category
- Accelerated filer<br>Emerging growth company
- Position in SEC ticker list
- #2321 of the 3,000 companies we track
Five-year financial highlights
Full-year figures from Alpha Tau Medical Ltd.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.
| Item | FY2021 ended Dec 31, 2021 | FY2022 ended Dec 31, 2022 | FY2023 ended Dec 31, 2023 | FY2024 ended Dec 31, 2024 | FY2025 ended Dec 31, 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Net income | -$27.3M | -$33.8M | -$29.2M | -$31.8M | -$42.6M |
| Diluted EPS | -$0.67 | -$0.53 | -$0.42 | -$0.45 | -$0.53 |
| Total assets | $42.2M | $120.1M | $107.4M | $86.2M | $105.7M |
| Cash and equivalents | $23.2M | $5.8M | $12.7M | $13.7M | $12.2M |
XBRL tags used: netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.
How to read these numbers
Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.
Advertisement
Latest key reports
The most recent filing of each major report type, even if it falls outside the 40 newest filings below.
Recent SEC filings
The 40 newest documents filed by or about Alpha Tau Medical Ltd., by form type:
| Filed | Form | What it is | Original |
|---|---|---|---|
| Oct 22, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Oct 22, 2026 | Document · Index |
| Oct 19, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Oct 19, 2026 | Document · Index |
| Aug 31, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Aug 31, 2026 | Document · Index |
| Aug 25, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 21, 2026 | Document · Index |
| Aug 21, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Aug 12, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Aug 11, 2026 | Document · Index |
| Aug 10, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Jun 30, 2026 | Document · Index |
| Aug 10, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Aug 10, 2026 | Document · Index |
| Jul 21, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Jul 21, 2026 | Document · Index |
| Jul 15, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Jul 15, 2026 | Document · Index |
| Jul 7, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 6, 2026 | Document · Index |
| Jul 6, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jul 6, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 2, 2026 | Document · Index |
| Jul 2, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jul 2, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jul 1, 2026 | Document · Index |
| Jul 1, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 30, 2026 | Document · Index |
| Jun 30, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jun 26, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jun 26, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 25, 2026 | Document · Index |
| Jun 25, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Jun 25, 2026 | Document · Index |
| Jun 25, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 23, 2026 | Document · Index |
| Jun 23, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jun 23, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Jun 23, 2026 | Document · Index |
| Jun 11, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Jun 11, 2026 | Document · Index |
| Jun 4, 2026 | 144 | Notice of proposed sale of securities | Document · Index |
| Jun 4, 2026 | 4 | Statement of changes in beneficial ownership (insider trade)· period Jun 3, 2026 | Document · Index |
| Jun 3, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Jun 3, 2026 | Document · Index |
| Jun 1, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period Jun 1, 2026 | Document · Index |
| May 18, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period May 18, 2026 | Document · Index |
| May 18, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period May 18, 2026 | Document · Index |
| May 11, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period May 11, 2026 | Document · Index |
| May 11, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period May 11, 2026 | Document · Index |
| May 8, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period May 8, 2026 | Document · Index |
| May 8, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period May 8, 2026 | Document · Index |
| May 7, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period May 7, 2026 | Document · Index |
| May 5, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period May 5, 2026 | Document · Index |
| May 4, 2026 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER· period May 4, 2026 | Document · Index |
| May 1, 2026 | EFFECT | EFFECT | Document · Index |
| Apr 30, 2026 | CORRESP | CORRESP | Document · Index |
| Apr 30, 2026 | UPLOAD | UPLOAD | Document · Index |
Insider filing activity
9 Form 4 filings appear in Alpha Tau Medical Ltd.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.
Advertisement
Other companies in Surgical & Medical Instruments & Apparatus
- SYK STRYKER CORP
- MMM 3M CO
- BSX BOSTON SCIENTIFIC CORP
- BDX BECTON DICKINSON & CO
- MDLN Medline Inc.
- RMD RESMED INC
- DXCM DEXCOM INC
- WST WEST PHARMACEUTICAL SERVICES INC
All 51 companies in Surgical & Medical Instruments & Apparatus
On Amazon
Popular tools for investors
As an Amazon Associate I earn from qualifying purchases.
Source
- U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001871321 and XBRL company facts. Alpha Tau Medical Ltd. on EDGAR.
- Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.
Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.
Advertisement